Wiebe K et al. |
FK506 rescue therapy in lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636613
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Platz KP et al. |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636596
|
Lang M et al. |
Impact of immunosuppression in liver transplantation across a positive crossmatch. |
1998 |
Transplant. Proc. |
pmid:9636595
|
Mueller AR et al. |
Does initial graft function influence the outcome after liver transplantation? |
1998 |
Transplant. Proc. |
pmid:9636594
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Bekersky I et al. |
Bioequivalence of a new strength tacrolimus capsule under development. |
1998 |
Transplant. Proc. |
pmid:9636591
|
Liu WT et al. |
In vitro generation of tacrolimus metabolites and their detection in whole blood. |
1998 |
Transplant. Proc. |
pmid:9636590
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Langrehr JM et al. |
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636583
|
Bilbao I et al. |
Experience with neoral cyclosporine through the oral route in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636580
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|